Annual Revenue
$2.05 M
+$528.00 K+34.67%
31 December 2023
Summary:
Lumos Pharma annual revenue is currently $2.05 million, with the most recent change of +$528.00 thousand (+34.67%) on 31 December 2023. During the last 3 years, it has risen by +$1.82 million (+791.74%).LUMO Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$726.00 K
+$238.00 K+48.77%
30 September 2024
Summary:
Lumos Pharma quarterly revenue is currently $726.00 thousand, with the most recent change of +$238.00 thousand (+48.77%) on 30 September 2024. Over the past year, it has dropped by -$100.00 thousand (-12.11%).LUMO Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$2.21 M
+$719.00 K+48.38%
30 September 2024
Summary:
Lumos Pharma TTM revenue is currently $2.21 million, with the most recent change of +$719.00 thousand (+48.38%) on 30 September 2024. Over the past year, it has increased by +$154.00 thousand (+7.51%).LUMO TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LUMO Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -12.1% | +7.5% |
| 3 y3 years | +791.7% | +230.0% | +858.7% |
| 5 y5 years | - | - | - |
LUMO Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -98.8% | -99.6% | -99.0% |
Lumos Pharma Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $726.00 K(+48.8%) | $2.21 M(+48.4%) |
| June 2024 | - | $488.00 K(+195.8%) | $1.49 M(-2.6%) |
| Mar 2024 | - | $165.00 K(-80.0%) | $1.52 M(-25.6%) |
| Dec 2023 | $2.05 M(+34.7%) | $826.00 K(>+9900.0%) | $2.05 M(+18.1%) |
| Sept 2023 | - | $7000.00(-98.7%) | $1.74 M(-22.0%) |
| June 2023 | - | $527.00 K(-23.7%) | $2.23 M(+0.6%) |
| Mar 2023 | - | $691.00 K(+35.0%) | $2.21 M(+35.5%) |
| Dec 2022 | $1.52 M(+562.2%) | $512.00 K(+3.0%) | $1.63 M(+21.8%) |
| Sept 2022 | - | $497.00 K(-3.3%) | $1.34 M(+58.8%) |
| June 2022 | - | $514.00 K(+363.1%) | $845.00 K(+147.8%) |
| Mar 2022 | - | $111.00 K(-49.5%) | $341.00 K(+48.3%) |
| Dec 2021 | $230.00 K(+36.9%) | $220.00 K(+2100.0%) | $230.00 K(+85.5%) |
| June 2021 | - | $10.00 K(-75.0%) | $124.00 K(-26.2%) |
| Dec 2020 | $168.00 K(-98.7%) | $40.00 K(-45.9%) | $168.00 K(+31.3%) |
| Sept 2020 | - | $74.00 K(+124.2%) | $128.00 K(+137.0%) |
| June 2020 | - | $33.00 K(+57.1%) | $54.00 K(+157.1%) |
| Mar 2020 | - | $21.00 K(-89.6%) | $21.00 K(-99.8%) |
| Dec 2018 | $12.47 M(-56.6%) | $202.00 K(+68.3%) | $12.47 M(-69.3%) |
| Sept 2018 | - | $120.00 K(-94.7%) | $40.65 M(+0.0%) |
| June 2018 | - | $2.25 M(-77.3%) | $40.63 M(-16.7%) |
| Mar 2018 | - | $9.90 M(-65.1%) | $48.75 M(+17.2%) |
| Dec 2017 | $28.71 M(-19.7%) | $28.38 M(>+9900.0%) | $41.61 M(-9.5%) |
| Sept 2017 | - | $103.00 K(-99.0%) | $45.99 M(-1.7%) |
| June 2017 | - | $10.37 M(+275.6%) | $46.78 M(+21.8%) |
| Mar 2017 | - | $2.76 M(-91.6%) | $38.42 M(-7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $35.77 M(-47.8%) | $32.76 M(+3589.2%) | $41.37 M(-2.8%) |
| Sept 2016 | - | $888.00 K(-55.9%) | $42.55 M(+0.1%) |
| June 2016 | - | $2.01 M(-64.8%) | $42.51 M(-11.3%) |
| Mar 2016 | - | $5.71 M(-83.2%) | $47.94 M(-41.1%) |
| Dec 2015 | $68.50 M(-60.3%) | $33.95 M(+3922.0%) | $81.43 M(-63.0%) |
| Sept 2015 | - | $844.00 K(-88.7%) | $220.08 M(+0.4%) |
| June 2015 | - | $7.45 M(-81.0%) | $219.23 M(+3.4%) |
| Mar 2015 | - | $39.20 M(-77.3%) | $212.00 M(+22.4%) |
| Dec 2014 | $172.59 M(>+9900.0%) | $172.59 M(>+9900.0%) | $173.14 M(>+9900.0%) |
| June 2014 | - | $212.00 K(-36.5%) | $1.64 M(-1.2%) |
| Mar 2014 | - | $334.00 K(-69.4%) | $1.66 M(+2.0%) |
| Dec 2013 | $1.09 M(-35.2%) | $1.09 M(+371.1%) | $1.63 M(-26.7%) |
| June 2013 | - | $232.00 K(-23.2%) | $2.22 M(-13.9%) |
| Mar 2013 | - | $302.00 K(-82.1%) | $2.58 M(-6.1%) |
| Dec 2012 | $1.69 M(-9.9%) | $1.69 M(+185.9%) | $2.75 M(+53.3%) |
| June 2012 | - | $590.00 K(+25.3%) | $1.79 M(+3.0%) |
| Mar 2012 | - | $471.00 K(+56.5%) | $1.74 M(-7.1%) |
| Dec 2011 | $1.87 M(+100.4%) | $301.00 K(-30.0%) | $1.87 M(+301.7%) |
| Sept 2011 | - | $430.00 K(-19.9%) | $466.00 K(+13.4%) |
| June 2011 | - | $537.00 K(-11.1%) | $411.00 K(-426.2%) |
| Mar 2011 | - | $604.00 K(-154.7%) | -$126.00 K(-82.7%) |
| Dec 2010 | - | -$1.10 M(-394.7%) | -$730.00 K(-170.1%) |
| Sept 2010 | - | $375.00 K(-43.7%) | $1.04 M(+56.3%) |
| Dec 2009 | $934.00 K(+47.6%) | $666.00 K | $666.00 K |
| Dec 2008 | $633.00 K | - | - |
FAQ
- What is Lumos Pharma annual revenue?
- What is the all time high annual revenue for Lumos Pharma?
- What is Lumos Pharma quarterly revenue?
- What is the all time high quarterly revenue for Lumos Pharma?
- What is Lumos Pharma quarterly revenue year-on-year change?
- What is Lumos Pharma TTM revenue?
- What is the all time high TTM revenue for Lumos Pharma?
- What is Lumos Pharma TTM revenue year-on-year change?
What is Lumos Pharma annual revenue?
The current annual revenue of LUMO is $2.05 M
What is the all time high annual revenue for Lumos Pharma?
Lumos Pharma all-time high annual revenue is $172.59 M
What is Lumos Pharma quarterly revenue?
The current quarterly revenue of LUMO is $726.00 K
What is the all time high quarterly revenue for Lumos Pharma?
Lumos Pharma all-time high quarterly revenue is $172.59 M
What is Lumos Pharma quarterly revenue year-on-year change?
Over the past year, LUMO quarterly revenue has changed by -$100.00 K (-12.11%)
What is Lumos Pharma TTM revenue?
The current TTM revenue of LUMO is $2.21 M
What is the all time high TTM revenue for Lumos Pharma?
Lumos Pharma all-time high TTM revenue is $220.08 M
What is Lumos Pharma TTM revenue year-on-year change?
Over the past year, LUMO TTM revenue has changed by +$154.00 K (+7.51%)